<DOC>
	<DOCNO>NCT01464229</DOCNO>
	<brief_summary>Iloperidone atypical antipsychotic drug , FDA-approved acute treatment schizophrenia adult 2009 ( Marino et al. , 2010 ) ; moreover , pharmacological feature seem promise treat symptom like anger anxiety ( Fava et al. , 1997 ; Wang et al. , 2010 ) . The investigator therefore feel adequately size , well power , double-blind , placebo-controlled , randomize , cross-over study iloperidone augmentation SSRIs among MDD outpatient partial remission residual anger irritability warrant point evaluate efficacy , safety tolerability residual anger , irritability depressive symptom . Main hypothesis : Adults MDD partial remission , experience residual symptom anger irritability , assign treatment iloperidone demonstrate significantly great reduction total score Anger/Hostility Scale Symptom Questionnaire baseline endpoint assign placebo use cross-over design .</brief_summary>
	<brief_title>Iloperidone Augmentation SSRIs Patients With Major Depressive Disorder With Residual Anger Irritability</brief_title>
	<detailed_description />
	<mesh_term>Disease</mesh_term>
	<mesh_term>Depressive Disorder</mesh_term>
	<mesh_term>Depression</mesh_term>
	<mesh_term>Depressive Disorder , Major</mesh_term>
	<criteria>Written inform consent . Men woman age 1865 year old . Current Major Depressive Episode partial remission base Structured Clinical Interview DSM IVAxis I Disorders ( SCID I/P ) HAMD17 score 9 15 . Current treatment selective serotonin reuptake inhibitor ( SSRI ) paroxetine fluoxetine least three month , stable dose past 4 week , 50 % le 75 % improvement current antidepressant , determine MGH Antidepressant Treatment Response Questionnaire ( ATRQ ) . Score &gt; 8 Anger/Hostility Scale Symptom Questionnaire screen baseline . The following DSMIV diagnosis : 1 ) organic mental disorder ; 2 ) substance use disorder , include alcohol , active within last 3 month ; 3 ) schizophrenia ; 4 ) delusional disorder ; 5 ) psychotic disorder elsewhere classify ; 6 ) bipolar disorder ; 9 ) antisocial personality disorder ; 10 ) dementia . Current , serious suicidal homicidal risk . Pregnancy breastfeed . Serious , unstable medical illness include cardiovascular , kidney , liver , neurological endocrine disorder . Congenital long QT syndrome QTc &gt; 450 ms. History cardiac arrhythmia . Electroconvulsive therapy ( ECT ) within 6 month precede baseline . Concomitant use buspirone , fluoxetine , paroxetine , psychostimulant , modafinil , antipsychotic drug , anticonvulsant ( although stable dos benzodiazepine hypnotic allow ) ( see Concomitant Therapy ) .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>April 2015</verification_date>
</DOC>